Limited Brands Q3
This article was originally published in The Rose Sheet
Executive Summary
Bath & Body Works comp store sales increased 9% in the third quarter, and net sales grew 9.3% to $350 mil., Limited Brands announces Nov. 18. Beauty retailer's operating income grew 1.3% to $4.6 mil., as anticipated, due to a profit plan that is heavily weighted to the fourth quarter, CEO Neil Fiske says in a conference call with analysts. Holiday plan, which began Oct. 18, is running ahead of expectations, exec notes, adding seasonal business has been up strongly compared to the prior year fueled by a "near doubling of our Perfect Christmas line and seasonal toiletries." Victoria's Secret Beauty sales have been driven by the success of sub-brands, such as Very Sexy for Her and Garden lip gloss, the firm adds. Victoria's Secret comp store sales increased 13%, net sales grew 13.2% to $830 mil., and operating income was up 12.9% to $107.2 mil...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.